
New Clinical Insights, Treatment Options, and Payer Management Strategies for IgA Nephropathy
This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/iga-nephropathy-ce/. IgA nephropathy (IgAN) is a progressive autoimmune kidney disease that can lead to kidney failure, substantial treatment burden, impaired quality of life, and significant health care costs. As understanding of IgAN pathogenesis advances and new targeted therapies expand the treatment landscape, managed care and payer professionals need current, practical guidance to evaluate emerging evidence, corticosteroid-related risks, network adequacy, and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.